Literature DB >> 23986595

A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production.

Laurent Chatel-Chaix1, Marie-Anne Germain, Alena Motorina, Éric Bonneil, Pierre Thibault, Martin Baril, Daniel Lamarre.   

Abstract

Hepatitis C virus (HCV) orchestrates the different stages of its life cycle in time and space through the sequential participation of HCV proteins and cellular machineries; hence, these represent tractable molecular host targets for HCV elimination by combination therapies. We recently identified multifunctional Y-box-binding protein 1 (YB-1 or YBX1) as an interacting partner of NS3/4A protein and HCV genomic RNA that negatively regulates the equilibrium between viral translation/replication and particle production. To identify novel host factors that regulate the production of infectious particles, we elucidated the YB-1 interactome in human hepatoma cells by a quantitative mass spectrometry approach. We identified 71 YB-1-associated proteins that included previously reported HCV regulators DDX3, heterogeneous nuclear RNP A1, and ILF2. Of the potential YB-1 interactors, 26 proteins significantly modulated HCV replication in a gene-silencing screening. Following extensive interaction and functional validation, we identified three YB-1 partners, C1QBP, LARP-1, and IGF2BP2, that redistribute to the surface of core-containing lipid droplets in HCV JFH-1-expressing cells, similarly to YB-1 and DDX6. Importantly, knockdown of these proteins stimulated the release and/or egress of HCV particles without affecting virus assembly, suggesting a functional YB-1 protein complex that negatively regulates virus production. Furthermore, a JFH-1 strain with the NS3 Q221L mutation, which promotes virus production, was less sensitive to this negative regulation, suggesting that this HCV-specific YB-1 protein complex modulates an NS3-dependent step in virus production. Overall, our data support a model in which HCV hijacks host cell machinery containing numerous RNA-binding proteins to control the equilibrium between viral RNA replication and NS3-dependent late steps in particle production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986595      PMCID: PMC3807372          DOI: 10.1128/JVI.01474-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  90 in total

Review 1.  Hepatitis C virus replication cycle.

Authors:  Ralf Bartenschlager; Francois-Loic Cosset; Volker Lohmann
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  From structure to function: new insights into hepatitis C virus RNA replication.

Authors:  Nicole Appel; Torsten Schaller; Francois Penin; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2005-12-30       Impact factor: 5.157

3.  YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules.

Authors:  Atsushi Kawaguchi; Ken Matsumoto; Kyosuke Nagata
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

4.  The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.

Authors:  Mahmut Yasen; Kazunori Kajino; Sayaka Kano; Hiroshi Tobita; Junji Yamamoto; Takeshi Uchiumi; Shigeyuki Kon; Masahiro Maeda; Gulanbar Obulhasim; Shigeki Arii; Okio Hino
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

5.  Cell culture and infection system for hepatitis C virus.

Authors:  Takanobu Kato; Tomoko Date; Asako Murayama; Kenichi Morikawa; Daisuke Akazawa; Takaji Wakita
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

Authors:  Robert Flisiak; Saya V Feinman; Maciej Jablkowski; Andrzej Horban; Wieslaw Kryczka; Małgorzata Pawlowska; Jenny E Heathcote; Giuseppe Mazzella; Carmen Vandelli; Valérie Nicolas-Métral; Pierre Grosgurin; Jorge S Liz; Pietro Scalfaro; Hervé Porchet; Raf Crabbé
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.

Authors:  Yasuo Ariumi; Misao Kuroki; Ken-ichi Abe; Hiromichi Dansako; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Authors:  Martin Baril; Marie-Eve Racine; François Penin; Daniel Lamarre
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

9.  Role of annexin A2 in the production of infectious hepatitis C virus particles.

Authors:  Perdita Backes; Doris Quinkert; Simon Reiss; Marco Binder; Margarita Zayas; Ursula Rescher; Volker Gerke; Ralf Bartenschlager; Volker Lohmann
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

10.  Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Authors:  Gregory Neveu; Rina Barouch-Bentov; Amotz Ziv-Av; Doron Gerber; Yves Jacob; Shirit Einav
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

View more
  27 in total

1.  Functional and Physical Interaction between the Arf Activator GBF1 and Hepatitis C Virus NS3 Protein.

Authors:  Nadjet Lebsir; Lucie Goueslain; Rayan Farhat; Nathalie Callens; Jean Dubuisson; Catherine L Jackson; Yves Rouillé
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Authors:  Christopher Ritchie; Isabel Cylinder; Emily J Platt; Eric Barklis
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

3.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

4.  A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.

Authors:  Laurent Chatel-Chaix; Wolfgang Fischl; Pietro Scaturro; Mirko Cortese; Stephanie Kallis; Marie Bartenschlager; Bernd Fischer; Ralf Bartenschlager
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis.

Authors:  Ng Desi; Qing Yun Tong; Velda Teh; Jia Jia Chan; Bin Zhang; Hossein Tabatabaeian; Hui Qing Tan; Katannya Kapeli; Wenhao Jin; Chun You Lim; Zhi Hao Kwok; Hwee Tong Tan; Shi Wang; Bei-En Siew; Kuok-Chung Lee; Choon-Seng Chong; Ker-Kan Tan; Henry Yang; Dennis Kappei; Gene W Yeo; Maxey Ching Ming Chung; Yvonne Tay
Journal:  Cell Mol Life Sci       Date:  2022-02-23       Impact factor: 9.261

6.  Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.

Authors:  Marie-Anne Germain; Laurent Chatel-Chaix; Bridget Gagné; Éric Bonneil; Pierre Thibault; Fabrine Pradezynski; Benoît de Chassey; Laurène Meyniel-Schicklin; Vincent Lotteau; Martin Baril; Daniel Lamarre
Journal:  Mol Cell Proteomics       Date:  2013-10-29       Impact factor: 5.911

Review 7.  Host restriction factors for hepatitis C virus.

Authors:  Li-Ya Zhou; Lei-Liang Zhang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

8.  Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.

Authors:  Wei-Ting Wang; Tsung-Yuan Tsai; Chi-Hong Chao; Bo-Ying Lai; Yan-Hwa Wu Lee
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

9.  Affinity Purification of the Hepatitis C Virus Replicase Identifies Valosin-Containing Protein, a Member of the ATPases Associated with Diverse Cellular Activities Family, as an Active Virus Replication Modulator.

Authors:  Zhigang Yi; Caiyun Fang; Jingyi Zou; Jun Xu; Wuhui Song; Xiaoting Du; Tingting Pan; Haojie Lu; Zhenghong Yuan
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

10.  The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches.

Authors:  Marco Mineo; Franz Ricklefs; Arun K Rooj; Shawn M Lyons; Pavel Ivanov; Khairul I Ansari; Ichiro Nakano; E Antonio Chiocca; Jakub Godlewski; Agnieszka Bronisz
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.